Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

A key Medicare fund is expected to show a –$1.8 billion budget authority in 2026, according to the CBO. The shift is part of ...

The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

The Trump administration announced deals with Novo Nordisk and Lilly to sell their weight loss products at a discounted rate ...

Medicare participants with an income above the threshold must pay a surcharge for Medicare Part B and Part D based on their ...

Democratic lawmakers have written a letter to the Centers for Medicare and Medicaid Services, criticizing the Trump ...

A recently proposed Medicare Administrative Contractors policy aims to restrict coverage for peripheral nerve blocks and related procedures used to treat chronic pain, but anesthesiologists and pain ...

A University of Minnesota Medical School research team has found that access to wheelchairs through Medicare-listed suppliers ...